Target intelligence / Profile preview

Lipid radical in phospholipid bilayer

Molecular classification
Other (organic radical species; not a protein, receptor, transporter, channel, or enzyme)
01

Overview

Lipid radicals are highly reactive chemical species, generated primarily during oxidative stress when free radicals (e.g., hydroxyl, superoxide) attack the fatty acid chains of phospholipids in the phospholipid bilayer, the fundamental component of all cellular membranes[1][6][7]. This initiates lipid peroxidation, a chain reaction that disrupts membrane structure, compromises barrier function, and propagates additional free radicals. The accumulation of lipid radicals can lead to membrane damage, altered membrane fluidity, and cell death pathways such as ferroptosis and apoptosis. Lipid radicals have a central role in the pathophysiology of diseases characterized by oxidative stress, including atherosclerosis, neurodegeneration, and cancer[3][4]. While not themselves a direct therapeutic target, the formation and propagation of lipid radicals are addressed pharmacologically by antioxidants and iron chelators which prevent or terminate free radical-driven damage to cellular membranes.

Other names
lipid radicalphospholipid bilayer lipid radicalmembrane lipid radicaloxidized lipid specieslipid peroxyl radical
02

Mechanism of action

Scavenging of lipid radicals to interrupt oxidative chain reactions Inhibition of lipid peroxidation Termination of free radical propagation in membranes

03

Biological functions

Membrane damagePropagation of lipid peroxidationInitiation of cell death (e.g., ferroptosis)Generation of reactive oxygen species
04

Disease associations

Cardiovascular disease (e.g., atherosclerosis)Neurodegenerative disease (e.g., Alzheimer’s, Parkinson’s)Cancer (contributes to carcinogenesis via DNA and membrane damage)Inflammation (oxidative stress)Other (aging, tissue injury)
05

Safety considerations

Lipid radical scavengers can affect normal redox signalingOff-target effects with high doses of antioxidantsIron chelators may induce anemia or other iron-deficiency syndromes
06

Interacting drugs

Antioxidants (Vitamin E, Trolox, certain polyphenols, edaravone)

1 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)4-Hydroxynonenal (4-HNE)F2-IsoprostanesLipid hydroperoxides

Beyond the preview

Go deeper on Lipid radical in phospholipid bilayer.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipid radical in phospholipid bilayer.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call